High Tower Advisors, LLC Champions Oncology, Inc. Transaction History
High Tower Advisors, LLC
- $68.3 Billion
- Q3 2024
A detailed history of High Tower Advisors, LLC transactions in Champions Oncology, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 39,308 shares of CSBR stock, worth $271,618. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,308
Previous 34,308
14.57%
Holding current value
$271,618
Previous $177,000
7.91%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CSBR
# of Institutions
25Shares Held
5.82MCall Options Held
0Put Options Held
15K-
Battery Management Corp. Boston, MA2.42MShares$16.7 Million3.63% of portfolio
-
Nea Management Company, LLC Timonium, MD1.71MShares$11.8 Million0.64% of portfolio
-
Tocqueville Asset Management L.P. New York, NY705KShares$4.87 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA307KShares$2.12 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny120KShares$829,1370.0% of portfolio
About CHAMPIONS ONCOLOGY, INC.
- Ticker CSBR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,522,400
- Market Cap $93.4M
- Description
- Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...